AccurKardia is an ECG-led diagnostics software company.
AccurKardia has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
AccurKardia's investors include Mayo Clinic, MedTech Innovator, Root NYC, Popular Impact Fund.
AccurKardia is headquartered in New York, United States.
AccurKardia is an ECG-led diagnostics software company.
AccurKardia is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AccurKardia — Funding & Investors." VCBacked, December 1, 2025, https://www.vcbacked.co/company/accurkardia. Accessed July 22, 2026.
VCBacked. (2025). AccurKardia — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/accurkardia
{{cite web |title=AccurKardia — Funding & Investors |url=https://www.vcbacked.co/company/accurkardia |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated